Genetic Technologies Settles Patent Dispute with Bioscientia Institute | GenomeWeb

NEW YORK (GenomeWeb News) – Genetic Technologies today announced it has settled a legal dispute with Bioscientia Institute for Medical Diagnostics and will withdraw its lawsuit against the German firm.

Melbourne, Australia-based GTG initiated legal action against Bioscientia in March related to GTG's non-coding technology. The company did not disclose details about the lawsuit, but GTG has sued numerous companies, alleging infringement of US Patent No. 5,612,179.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: tool to discover copy number variants, single-nucleus RNA sequencing study of myoblasts, and more.

A study of Tasmanian devil genomes suggests they are evolving resistance to devil facial tumor disease.

Theranos has withdrawn its request for emergency clearance of a Zika virus blood test, according to the Wall Street Journal.

An assistant professor who was fired from Mount Sinai School of Medicine has allegedly shot the school's dean, the New York Times reports.